Skip to main content

Advertisement

SpringerLink
Log in

Complexation approach for fixed dose tablet formulation of lopinavir and ritonavir: an anomalous relationship between stability constant, dissolution rate and saturation solubility

  • Original Article
  • Published:
Journal of Inclusion Phenomena and Macrocyclic Chemistry Aims and scope Submit manuscript

Abstract

In the present investigation, cyclodextrin complexation process was explored for development of tablet formulation of WHO approved fixed dose combination of lopinavir and ritonavir with reduced tablet size, shorter disintegration time and higher bio-availability in comparison to reference product. In preliminary studies, we found that lopinavir solubility and dissolution rate is poor into the dissolution medium recommended by FDA, whereas ritonavir solubilized fairly into dissolution medium with adequate dissolution rate. Solid-state cyclodextrin complexation technology was used for enhancement of dissolution rate of lopinavir into dissolution medium. Various cyclodextrins were screened by comparison on basis of enhancement of dissolution rate of lopinavir (LPV) and the order was found as gamma cyclodextrin (γ-CD) > hydroxypropyl beta-cyclodextrin (HP-β-CD) > methyl beta-cyclodextrin (M-β-CD) > beta-cyclodextrin (β-CD), with Q120 values (i.e. percentage of dissolved drug at 120 min.) were 10.1 for the pure LPV and 56.3, 51.3, 30.3 and 10.3 for LPV/γ-CD, LPV/HP-β-CD, LPV/M-β-CD and LPV/β-CD, respectively. Anomalous results were found between stability constant, dissolution rate and saturation solubility. It was found that cyclodextrin having higher stability constant value with LPV, provides higher saturated solubility of LPV in aqueous media but at slow dissolution rate and vice versa. The γ-CD was selected for complexation with lopinavir in the stoichiometric ratio 1:1.5 M of LPV to γ-CD. Various processes such as kneading method, milling technique, sonication, freeze drying and autoclaving were tried, from which kneading method was found to give best dissolution results. The corresponding solid complexes were characterized by differential scanning calorimetric, X-ray powder diffraction and scanning electron microscopy studies. Based on various studies, the complexation phenomenon between LPV and γ-CD was found to follow non-inclusion behavior. Pharmacokinetic studies were carried out in Sprague-Dawley rats using cross over design with a 3 day wash out period. The bioavailability of lopinavir was found to be enhanced significantly using cyclodextrin complex tablet formulation.

Graphical Abstract

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10
Fig. 11
Fig. 12
Fig. 13
Fig. 14

Similar content being viewed by others

References

  1. Roberts, N.A., Martin, J.A., Kinchington, D., Broadhurst, A.V., Craig, J.C., Duncan, I.B., Galpin, S.A., Handa, B.K., Kay, J., Krohn, A., Lambert, R.W., Merrett, J.H., Mills, J.S., Parkes, K.E.B., Redshaw, S., Ritchie, A.J., Taylor, D.L., Thomas, G.J., Machin, P.J.: Rational design of peptide-based HIV proteinase inhibitors. Science 248, 358–361 (1990)

    Article  CAS  Google Scholar 

  2. Richman, D.D.: HIV chemotherapy. Nature 410, 995–1001 (2001)

    Article  CAS  Google Scholar 

  3. Boffito, M., Dickinson, L., Hill, A., Back, D., Moyle, G., Nelson, M., Higgs, C., Fletcher, C., Mandalia, S., Gazzard, B., Pozniak, A.: Pharmacokinetics of once-daily saquinavir/ritonavir in HIV-infected subjects: comparison with the standard twice-daily regimen. Antivir. Ther. 9, 423–429 (2004)

    CAS  Google Scholar 

  4. Ribera, E., Lopez, R.M., Diaz, M., Pou, L., Ruiz, L., Falco, V., Crespo, M., Azuaje, C., Ruiz, I., Ocana, I., Clotet, B., Pahissa, A.: Steady-state pharmacokinetics of a double-boosting regimen of saquinavir soft gel plus lopinavir plus minidose ritonavir in human immunodeficiency virus-infected adults. Antimicrob. Agents Chemother. 48, 4256–4262 (2004)

    Article  CAS  Google Scholar 

  5. Lang, M., Roesel, J.L.: HIV-1 protease inhibitors: development, status, and potential role in the treatment of AIDS. Arch. Pharm. 326, 921–924 (1993)

    Article  CAS  Google Scholar 

  6. Robins, T., Plattner, J.: HIV protease inhibitors: their anti-HIV activity and potential role in treatment. J. AIDS 6, 162–170 (1993)

    CAS  Google Scholar 

  7. Zeldin, R.K., Petruschke, R.A.: Pharmacological and therapeutic properties of ritonavir-boosted protease inhibitor therapy in HIV-infected patients. J. Antimicrob. Chemother. 53, 4–9 (2004)

    Article  CAS  Google Scholar 

  8. Zhu, T., Chiu, Y., Doan, T., Klein, C., Chang, M., Brun, S., Hanna, G., Awni, W.: New tablet formulation of Lopinavir/Ritonavir is bioequivalent to the capsule at a dose of 800/200 mg. 45th Interscience Conference on Antimicrobial Agents and Chemotherapy. Poster H-1894 (2005)

  9. Fukushima, K., Terasaka, S., Haraya, K., Kodera, S., Seki, Y., Wada, A., Ito, Y., Shibata, N., Sugioka, N., Takada, K.: Pharmaceutical approach to HIV protease inhibitor atazanavir for bioavailability enhancement based on solid dispersion system. Biol. Pharm. Bull. 30, 733–738 (2007)

    Article  CAS  Google Scholar 

  10. Kupferschmidt, H.H., Fattinger, K.E., Ha, H.R., Follath, F., Krahenbuhl, S.: Grapefruit juice enhances the bioavailability of the HIV protease inhibitor saquinavir in man. Br. J. Clin. Pharmacol. 45, 355–359 (1998)

    Article  CAS  Google Scholar 

  11. Griffin, B.T., Driscoll, C.M.: A comparison of intestinal lymphatic transport and systemic bioavailability of saquinavir from three lipid-based formulations in the anaesthetized rat model. J. Pharm. Pharmacol. 58, 917–925 (2006)

    Article  CAS  Google Scholar 

  12. Betageri, G.V., Deshmukh, D.V., Gupta, R.B.: Oral sustained-release bioadhesive tablet formulation of didanosine. Drug Dev. Ind. Pharm. 27, 129–136 (2001)

    Article  CAS  Google Scholar 

  13. De Jaeghere, F., Allemann, E., Kubel, F., Galli, B., Cozens, R., Doelker, E., Gurny, R.: Oral bioavailability of a poorly water soluble HIV-1 protease inhibitor incorporated into pH-sensitive particles: effect of the particle size and nutritional state. J. Control. Release 68, 291–298 (2000)

    Article  Google Scholar 

  14. Eerdenbrugh, B.V., Froyen, L., Martens, J.A., Blaton, N., Augustijns, P., Brewster, M., Mooter, G.V.: Characterization of physico-chemical properties and pharmaceutical performance of sucrose co-freeze-dried solid nanoparticulate powders of the anti-HIV agent loviride prepared by media milling. Int. J. Pharm. 338, 198–206 (2007)

    Article  Google Scholar 

  15. Torne, J.S., Vavia, P.R.: Inclusion complexation of anti-HIV drug with β-cyclodextrin. J. Incl. Phenom. Macrocycl. Chem. 56, 253–259 (2006)

    Article  CAS  Google Scholar 

  16. Loftsson, T., Jarho, P., Masson, M., Jarvinen, T.: Cyclodextrins in drug delivery. Expert Opin. Drug Deliv. 2, 335–351 (2005)

    Article  CAS  Google Scholar 

  17. Higuchi, T., Connors, K.A.: Phase-solubility techniques. Adv. Anal. Chem. Instr. 4, 117–212 (1965)

    CAS  Google Scholar 

  18. Loftsson, T., Hreinsdottir, D., Masson, M.: Evaluation of cyclodextrin solubilization of drugs. Int. J. Pharm. 302, 18–28 (2005)

    Article  CAS  Google Scholar 

  19. Guo, J., Ping, Q., Jiang, G., Dong, J., Qi, S., Feng, L., Li, Z., Li, C.: Transport of leuprolide across rat intestine, rabbit intestine and Caco-2 cell monolayer. Int. J. Pharm. 278, 415–422 (2008)

    Article  Google Scholar 

  20. Jadhav, G.S., Vavia, P.R., Nandedkar, T.D.: Danazol-β-cyclodextrin binary system: a potential application in emergency contraception by the oral route. AAPSPharmSciTech. 8, Article 35 (2007)

  21. Bilensoy, E., Rouf, M.A., Vural, I., Şen, M., Hıncal, A.A.: Mucoadhesive, thermosensitive, prolonged-release vaginal gel for clotrimazole: β-cyclodextrin complex. AAPS PharmSciTech. 7 (2006)

  22. Boffito, M., Else, L., Back, D., Taylor, J., Khoo, S., Sousa, M., Pozniak, A., Gazzard, B., Moyle, G.: Pharmacokinetics of atazanavir/ritonavir once daily and lopinavir/ritonavir twice and once daily over 72 h following drug cessation. Antivir. Ther. 13, 901–907 (2008)

    CAS  Google Scholar 

  23. Bai, Y., Xu, G.Y., Xin, X., Sun, H.Y., Zhang, H.X., Hao, A.Y., Yang, X.D., Yao, L.: Interaction between cetyltrimethylammonium bromide and β-cyclodextrin: surface tension and interfacial dilational viscoelasticity studies. Colloid. Polym. Sci. 286, 1475–1484 (2008)

    Article  CAS  Google Scholar 

  24. Onclin, S., Mulder, A., Huskens, J., Ravoo, B.J., Reinhoudt, D.N.: Molecular printboards: # monolayers of β-cyclodextrins on silicon oxide surfaces. Langmuir 20, 5460–5466 (2004)

    Article  CAS  Google Scholar 

Download references

Acknowledgments

Gaurav Goyal would like to acknowledge financial assistance in the form of a postgraduate research scholarship from the University Grants Commission, India funded by the Major Research Project under Xth Plan and AICTE to provide sponsorship towards development of instrumentation facilities under NAFETIC scheme.

Author information

Authors and Affiliations

  1. Center for Novel Drug Delivery Systems (NAFETIC, AICTE), Department of Pharmaceutical Sciences and Technology, Institute of Chemical Technology, Matunga, Mumbai, 400 019, India

    Gaurav Goyal & Pradeep R. Vavia

Authors
  1. Gaurav Goyal
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Pradeep R. Vavia
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Pradeep R. Vavia.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Goyal, G., Vavia, P.R. Complexation approach for fixed dose tablet formulation of lopinavir and ritonavir: an anomalous relationship between stability constant, dissolution rate and saturation solubility. J Incl Phenom Macrocycl Chem 73, 75–85 (2012). https://doi.org/10.1007/s10847-011-0022-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10847-011-0022-7

Keywords

Search

Navigation